Optimal administration frequency and dose of teriparatide for acceleration of biomechanical healing of long-bone fracture in a mouse model

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Journal of Bone and Mineral Metabolism

• Publication date

  2019-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00774-018-0930-3PMID 29721806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute development of cortical porosity and endosteal naïve bone formation from the daily but not weekly short-term administration of PTH in rabbit

  2017cited by this paper
• Comparison of the effects of once‐weekly and once‐daily rhPTH (1–34) injections on promoting fracture healing in rodents

  2017cited by this paper
• Administration frequency as well as dosage of PTH are associated with development of cortical porosity in ovariectomized rats

  2017cited by this paper
• Increased cortical porosity is associated with daily, not weekly, administration of equivalent doses of teriparatide.

  2017cited by this paper
• Frequency of Teriparatide Administration Affects the Histological Pattern of Bone Formation in Young Adult Male Mice.

  2016cited by this paper
• Vitamin K-dependent carboxylation of osteocalcin affects the efficacy of teriparatide (PTH(1-34)) for skeletal repair.

  2014cited by this paper
• Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee

  2013cited by this paper
• Endogenous tissue engineering: PTH therapy for skeletal repair

  2012cited by this paper
• Teriparatide Accelerates Lumbar Posterolateral Fusion in Women With Postmenopausal Osteoporosis: Prospective Study

  2012cited by this paper
• The role of the liver and kidneys in the pharmacokinetics of subcutaneously administered teriparatide acetate in rats

  2012cited by this paper
• Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis

  2010cited by this paper
• Successful treatment of sternal fracture nonunion with teriparatide

  2010cited by this paper
• Guidelines for assessment of bone microstructure in rodents using micro–computed tomography

  2010cited by this paper
• Teriparatide May Accelerate Healing in Delayed Unions of Type III Odontoid Fractures: A Report of 3 Cases

  2010cited by this paper
• Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double‐blind study of 102 postmenopausal women with distal radial fractures

  2010cited by this paper
• Vitamin K2 Promotes Bone Healing in a Rat Femoral Osteotomy Model with or without Glucocorticoid Treatment

  2010cited by this paper
• Atrophic humeral shaft nonunion treated with teriparatide (rh PTH 1-34): a case report.

  2010cited by this paper
• Development of a stable closed femoral fracture model in mice.

  2009cited by this paper
• Quantitative measures of femoral fracture repair in rats derived by micro-computed tomography.

  2009cited by this paper
• Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats.

  2008cited by this paper
• Enhanced Chondrogenesis and Wnt Signaling in PTH‐Treated Fractures

  2007cited by this paper
• Transosseous application of low-intensity ultrasound for the enhancement and monitoring of fracture healing process in a sheep osteotomy model.

  2006cited by this paper
• Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora.

  2005cited by this paper
• Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.

  2005cited by this paper
• Treatment with Parathyroid Hormone hPTH(1-34), hPTH(1-31), and Monocyclic hPTH(1-31) Enhances Fracture Strength and Callus Amount After Withdrawal Fracture Strength and Callus Mechanical Quality Continue to Increase

  2004cited by this paper
• Teriparatide [PTH(1–34)] Strengthens the Proximal Femur of Ovariectomized Nonhuman Primates Despite Increasing Porosity

  2004cited by this paper
• Microtubules Mediate Germ-nuclear Behavior after Meiosis in Conjugation of Paramecium caudatum

  2002cited by this paper
• Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

  2001cited by this paper
• Intermittently Administered Human Parathyroid Hormone(1–34) Treatment Increases Intracortical Bone Turnover and Porosity Without Reducing Bone Strength in the Humerus of Ovariectomized Cynomolgus Monkeys

  2001cited by this paper
• Parathyroid hormone (1-34) increases the density of rat cancellous bone in a bone chamber

  2000cited by this paper
• Parathyroid hormone (1-34) increases the density of rat cancellous bone in a bone chamber. A dose-response study.

  2000cited by this paper
• Intermittent Parathyroid Hormone (1–34) Treatment Increases Callus Formation and Mechanical Strength of Healing Rat Fractures

  1999cited by this paper
• The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats.

  1997cited by this paper
• Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients.

  1993cited by this paper

• Strontium-Loaded Titanium and Systemic Teriparatide Synergistically Enhance Osteogenesis and Osseointegration in an Osteoporotic Rabbit Model.

  2025cites this paper
• 3D printed Gel/PTH@PAHA scaffolds with both enhanced osteogenesis and mechanical properties for repair of large bone defects

  2025cites this paper
• Preoperative abaloparatide plus zoledronate treatment accelerates femoral bone healing in rats following osteotomy

  2024cites this paper
• Development, Validation and Characterization of a Novel Portable Closed Fracture Device

  2023cites this paper
• Dynamic morphometric changes in the mandibular osteocytic lacunae of ovariectomized rats in response to teriparatide, as revealed by three-dimensional fluorescence analyses: Possible involvement of osteocytic perilacunar remodeling.

  2023cites this paper
• Protective effect of Du-Zhong-Wan against osteoporotic fracture by targeting the osteoblastogenesis and angiogenesis couple factor SLIT3.

  2022cites this paper
• PTH1-34 improves devitalized allogenic bone graft healing in a murine femoral critical size defect.

  2021cites this paper
• Effect of weekly teriparatide injections on osteoporotic fracture healing: protocol for a double-blind, randomised controlled trial

  2021cites this paper
• Effects of the different administration frequencies of teriparatide (PTH [1-34]) on new bone formation of expanded midpalatal sutures in rats: A histomorphometric and microcomputed tomography analysis.

  2021cites this paper
• The effects of different doses of teriparatide on bisphosphonate-related osteonecrosis of the jaw in mice.

  2020cites this paper
• The Treatment of Acute Diaphyseal Long-bones Fractures with Orthobiologics and Pharmacological Interventions for Bone Healing Enhancement: A Systematic Review of Clinical Evidence

  2020cites this paper
• The biology and treatment of acute long-bones diaphyseal fractures: Overview of the current options for bone healing enhancement

  2020cites this paper
• Effects of teriparatide versus percutaneous vertebroplasty on pain relief, quality of life and cost-effectiveness in postmenopausal females with acute osteoporotic vertebral compression fracture: A prospective cohort study.

  2019cites this paper
• Effects of Intermittent Administration of Parathyroid Hormone and Parathyroid Hormone‐Related Protein on Fracture Healing: A Narrative Review of Animal and Human Studies

  2019cites this paper
• Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation

  2019cites this paper
• Parathyroid hormone for bone regeneration

  2018cites this paper